FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

J W R Nortier

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
T J A Dekker; G K J Hooijer; Wilma E Mesker; J W R Nortier; Vincent T H B M Smit; R A E M Tollenaar; M J Van de Vijver; Judith R Kroep
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
F L Opdam; C H Smorenburg; R Vree; A S Modak; J W R Nortier; E Batman; Jan den Hartigh; V O Dezentje; Hans Gelderblom; Henk-Jan Guchelaar
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
A M Algra; J W R Nortier
[Aspirin and cancer: evidence of a prophylactic effect].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of J W R Nortier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: T J A Dekker; G K J Hooijer; Wilma E Mesker; J W R Nortier; Vincent T H B M Smit; R A E M Tollenaar; M J Van de Vijver; Judith R Kroep
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):931-7.
2013: F L Opdam; C H Smorenburg; R Vree; A S Modak; J W R Nortier; E Batman; Jan den Hartigh; V O Dezentje; Hans Gelderblom; Henk-Jan Guchelaar
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
Cancer chemotherapy and pharmacology 2013;71(3):593-601.
2013: A M Algra; J W R Nortier
[Aspirin and cancer: evidence of a prophylactic effect].
Nederlands tijdschrift voor geneeskunde 2013;157(17):A5189.
2012: D B Y Fontein; Hans Gelderblom; Henk-Jan Guchelaar; E T M Hille; D Houtsma; E Meershoek-Klein Kranenbarg; J W R Nortier; R Paridaens; Hein Putter; Caroline Seynaeve; C J H van de Velde; J M S Bartlett; L Y Dirix
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(12):3091-7.
2012: C J G van den Hurk; W P M Breed; J W R Nortier
Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(12):3255-60.
2012: L N van Steenbergen; A N M Wymenga; V E P P Lemmens; J W R Nortier; H J T Rutten; M L G Janssen-Heijnen
Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(11):2805-11.
2012: J H M J Vestjens; C H M van Deurzen; Paulus van Diest; J A A M van Dijck; E M M Adang; G F Borm; Peter Bult; M de Boer; M B E Menke-Pluymers; J W R Nortier; M J Pepels; E J Th Rutgers; C Seynaeve; V C G Tjan-Heijnen
Relevant impact of central pathology review on nodal classification in individual breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2561-6.
2012: M Heusinkveld; J C Jansen; A P M Langeveld; J W R Nortier; V T H B M Smit; R J P Briet; Hans Gelderblom; R Goedemans; A Gorter; Sjoerd H van der burg
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
International journal of cancer. Journal international du cancer 2012;131(2):E74-85.
2012: J G H van Nes; Dorien W Voskuil; Flora E van Leeuwen; J C J M de Haes; D B Y Fontein; E T M Hille; J W R Nortier; Hein Putter; Caroline Seynaeve; C J H van de Velde
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.
Breast cancer research and treatment 2012;134(1):267-76.
2012: C M T Schilder; Caroline Seynaeve; Frits S A M van Dam; C J H van de Velde; L V A M Beex; Willem Boogerd; Chad Gundy; Sabine C Linn; J W R Nortier; Sanne B Schagen
Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Psycho-oncology 2012;21(5):479-87.
2012: D B Y Fontein; GJ Liefers; E Maartense; E Meershoek-Klein Kranenbarg; J W R Nortier; Hein Putter; E J Th Rutgers; J van den Bosch; C J H van de Velde
High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(2):110-7.
2012: C C E Koning; J W R Nortier
[Re-irradiation of painful bone metastases].
Nederlands tijdschrift voor geneeskunde 2012;156(41):A5296.
2012: Marije Slingerland; Judith R Kroep; Astrid N Scholten; GJ Liefers; J W R Nortier
[Pregnancy-associated breast cancer: current opinions on diagnosis and treatment].
Nederlands tijdschrift voor geneeskunde 2012;156(40):A5286.
2011: S van de Ven; T J A Dekker; J W R Nortier; V T H B M Smit; Judith R Kroep
Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.
Cancer treatment reviews 2011;37(6):422-30.
2011: A A Aaldriks; Ben A Blansjaar; Erik J Giltay; W M Kloosterman-Boele; S le Cessie; E Maartense; M T Peters-Dijkshoorn; L G M van der Geest; Henry W van Schaick; H A C M Verlaan; J W R Nortier
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.
Critical reviews in oncology/hematology 2011;79(2):205-12.
2011: RI Lalisang; O J L Loosveld; J W R Nortier; C J Rodenburg; Peter Slee; A E M Smals; Vivianne C G Tjan-Heijnen; Aart van Bochove; E E Voest; Jacob Wals; J A Wils; G H Blijham; F L G Erdkamp; C T A M Knibbeler-van Rossum; H C Schouten
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Breast cancer research and treatment 2011;128(2):437-45.
2011: Neeltje Steeghs; Hans Gelderblom; Judith Wessels; Ferry A L M Eskens; Natasja de Bont; J W R Nortier; Henk-Jan Guchelaar
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.
Investigational new drugs 2011;29(1):137-43.
2011: Marion M C Komen; Carolien H Smorenburg; Corina J G van den Hurk; J W R Nortier
[Scalp cooling for chemotherapy-induced alopecia].
Nederlands tijdschrift voor geneeskunde 2011;155(45):A3768.
2010: C M T Schilder; C Seynaeve; S C Linn; Willem Boogerd; L V A M Beex; Chad Gundy; J W R Nortier; C J H van de Velde; Frits S A M van Dam; Sanne B Schagen
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.
Critical reviews in oncology/hematology 2010;76(2):133-41.
2010: Judith R Kroep; S C Linn; Epie Boven; H J Bloemendal; J Baas; I A M Mandjes; J van den Bosch; W M Smit; H de Graaf; C P Schröder; G J Vermeulen; W C J Hop; J W R Nortier
Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.
The Netherlands journal of medicine 2010;68(9):371-6.
2010: L B J van Iersel; M Koopman; C J H van de Velde; L Mol; EL van Persijn van Meerten; Henk H Hartgrink; Peter Kuppen; Alexander L Vahrmeijer; J W R Nortier; R A E M Tollenaar; Cornelis J A Punt; Hans Gelderblom
Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(8):1662-7.
2010: J M Baas; Ellen Kapiteijn; Alberto M Pereira; J W R Nortier
Atypical Cushing's syndrome caused by ectopic ACTH secretion of an oesophageal adenocarcinoma.
The Netherlands journal of medicine 2010;68(6):265-7.
2010: Vincent O Dezentjé; Nico J C van Blijderveen; Hans Gelderblom; Hein Putter; Myrthe van Herk-Sukel; Mariel Casparie; Antoine C G Egberts; J W R Nortier; Henk-Jan Guchelaar
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(14):2423-9.
2010: J G H van Nes; Caroline Seynaeve; S Jones; Christos Markopoulos; Hein Putter; C J H van de Velde; A Hasenburg; D W Rea; J-M Vannetzel; L Dirix; Y Hozumi; M J Kerin; D G Kieback; W M Meershoek-Klein Kranenbarg; E T M Hille; J W R Nortier
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.
The British journal of surgery 2010;97(5):671-9.
2010: J G H van Nes; Caroline Seynaeve; E Maartense; R M H Roumen; Robert S de Jong; Louk V A M Beex; W M Meershoek-Klein Kranenbarg; Hein Putter; J W R Nortier; C J H van de Velde
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(5):974-82.
2010: M A J van de Sande; Corina J G van den Hurk; Wim P M Breed; J W R Nortier
[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur].
Nederlands tijdschrift voor geneeskunde 2010;154():A2134.
2009: Neeltje Steeghs; Ferry A L M Eskens; Hans Gelderblom; Jaap Verweij; J W R Nortier; Jan Ouwerkerk; Conny van Noort; Mariangela Mariani; Riccardo Spinelli; Patrizia Carpinelli; Bernard Laffranchi; Maja J A de Jonge
Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5094-101.
2009: Ferry A L M Eskens; Neeltje Steeghs; Jaap Verweij; Johan L Bloem; Olaf Christensen; Leni van Doorn; Jan Ouwerkerk; M J A de Jonge; J W R Nortier; Joern Kraetzschmar; Prabhu Rajagopalan; Hans Gelderblom
Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4169-76.
2009: Dinemarie Kweekel; N F Antonini; J W R Nortier; C J A Punt; Hans Gelderblom; Henk-Jan Guchelaar
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
British journal of cancer 2009;101(2):357-62.
2009: F J S H Woei-A-Jin; Ellen Kapiteijn; J W R Nortier; S Osanto
Abdominal pain, low grade fever and persistent shock.
The Netherlands journal of medicine 2009;67(7):288-92.
2008: H Struikmans; J W R Nortier; E J Th Rutgers; H M Zonderland; M Bontenbal; P H M Elkhuizen; G van Tienhoven; V C G Tjan-Heijnen; T van Vegchel; M K Tuut; J Benraadt
[Guideline 'Treatment of breast cancer 2008' (revision)].
Nederlands tijdschrift voor geneeskunde 2008;152(46):2507-11.
2008: E Jenninga; J R Kroep; C G J M Hilders; L A Louwé; H J Verburg; J W R Nortier
[Fertility preservation in female oncology patients].
Nederlands tijdschrift voor geneeskunde 2008;152(45):2437-41.
2008: Dinemarie Kweekel; M Koopman; N F Antonini; Tahar van der Straaten; J W R Nortier; Hans Gelderblom; C J A Punt; Henk-Jan Guchelaar
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
British journal of cancer 2008;99(8):1316-21.
2008: Liselot B J van Iersel; Ellen J Hoekman; Hans Gelderblom; Alexander L Vahrmeijer; EL van Persijn van Meerten; F G J Tijl; Henk H Hartgrink; Peter Kuppen; J W R Nortier; R A E M Tollenaar; Cornelis J H van de Velde
Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases.
Annals of surgical oncology 2008;15(7):1891-8.
2008: L B J van Iersel; Hans Gelderblom; Alexander L Vahrmeijer; EL van Persijn van Meerten; F G J Tijl; Hein Putter; Henk H Hartgrink; Peter Kuppen; J W R Nortier; R A E M Tollenaar; C J H van de Velde
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1127-34.
2008: R A Nout; Willem E Fiets; H Struikmans; F R Rosendaal; Hein Putter; J W R Nortier
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer.
Breast cancer research and treatment 2008;109(3):567-72.
2007: Nielka P H van Erp; Hans Gelderblom; Mats O Karlsson; Jing Li; Ming Zhao; Jan Ouwerkerk; J W R Nortier; Henk-Jan Guchelaar; Sharyn D Baker; Alex Sparreboom
Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7394-400.
2007: Neeltje Steeghs; J W R Nortier; Hans Gelderblom
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments.
Annals of surgical oncology 2007;14(2):942-53.
2007: M Venturini; R Paridaens; D Rossner; M M Vaslamatzis; J W R Nortier; M Salzberg; H Rodrigues; R Bell
An open-label, multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer.
Oncology 2007;72(1-2):51-7.
2007: Leilani Morales; Peter Canney; Jaroslaw Dyczka; Emiel Rutgers; Robert Coleman; Tanja Cufer; Marzena Welnicka-Jaskiewicz; J W R Nortier; Jan Bogaerts; Patrick Therasse; Robert Paridaens
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
European journal of cancer (Oxford, England : 1990) 2007;43(2):331-40.
2006: J G H van Nes; C Seynaeve; Cornelis J H van de Velde; J W R Nortier
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
Nederlands tijdschrift voor geneeskunde 2006;150(52):2863-9.
2006: J R Kroep; Hans Gelderblom; A F S Collen; J W R Nortier
[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor].
Nederlands tijdschrift voor geneeskunde 2006;150(46):2555-9.
2006: T Netelenbos; Marianne A Nooij; J W R Nortier
Diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer.
The Netherlands journal of medicine 2006;64(8):310-3.
2006: W Chr Kleijn; K Ogoshi; K Yamaoka; T Shigehisa; Y Takeda; Carien L Creutzberg; J W R Nortier; Adrian A Kaptein
Conceptual equivalence and health-related quality of life: an exploratory study in Japanese and Dutch cancer patients.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(6):1091-101.
2006: Geke A P Hospers; M Schaapveld; J W R Nortier; Jacques A Wils; Aart van Bochove; Robert S de Jong; Geert-Jan Creemers; Z Erjavec; D J de Gooyer; Peter Slee; C J H Gerrits; JM Smit; Nanno H Mulder
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):443-9.
2006: Peter Barrett-Lee; Heinz Ludwig; Gunnar Birgegård; Carsten Bokemeyer; Pere Gascón; Paris A Kosmidis; Maciej Krzakowski; J W R Nortier; Gail Kongable; Maurice Schneider; Dirk Schrijvers; Simon van Belle
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
Oncology 2006;70(1):34-48.
2005: Nielka P H van Erp; Sharyn D Baker; Ming Zhao; MICHELLE RUDEK-RENAUT; Henk-Jan Guchelaar; J W R Nortier; Alex Sparreboom; Hans Gelderblom
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7800-6.
2005: Peter Barrett-Lee; Carsten Bokemeyer; Pere Gascón; J W R Nortier; Maurice Schneider; Dirk Schrijvers; Simon van Belle
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
The oncologist 2005;10(9):743-57.
2005: S J T Jansen; Wilma Otten; M C M Baas-Thijssen; Cornelis J H van de Velde; J W R Nortier; Anne M Stiggelbout
Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6623-30.
2005: Daniel W Rea; J W R Nortier; Wim W ten Bokkel Huinink; SJ Falk; D J Richel; Timothy S Maughan; Gerard Groenewegen; JM Smit; Neil M Steven; J M Bakker; D Semiond; David J Kerr; Cornelis J A Punt
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1123-32.
2005: Willem E Fiets; F E Bellot; Henk Struikmans; M A Blankenstein; J W R Nortier
Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(2):128-33.
2005: J J Arends; H P Sleeboom; M B L Leys; D Ten Bokkel Huinink; Robert S de Jong; JM Smit; J W R Nortier; M E T Tesselaar
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma.
British journal of cancer 2005;92(3):445-8.
2005: John F R Robertson; Steven E Come; Stephen E Jones; Louk V A M Beex; M Kaufmann; Andreas Makris; J W R Nortier; K Possinger; L-E Rutqvist
Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
European journal of cancer (Oxford, England : 1990) 2005;41(3):346-56.
2004: Peter Slee; Cees J Rodenburg; J W R Nortier; Aart van Bochove
A phase I dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer.
The Netherlands journal of medicine 2004;62(9):314-9.
2004: Heinz Ludwig; Simon van Belle; Peter Barrett-Lee; Gunnar Birgegård; Carsten Bokemeyer; Pere Gascón; Paris A Kosmidis; Maciej Krzakowski; J W R Nortier; Patrizia Olmi; Maurice Schneider; Dirk Schrijvers
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2293-306.
2004: Joost Rothbarth; R A E M Tollenaar; J H M Schellens; J W R Nortier; Leo J Schultze Kool; Peter Kuppen; Gerard J Mulder; Cornelis J H van de Velde
Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
European journal of cancer (Oxford, England : 1990) 2004;40(12):1812-24.
2004: J W R Nortier
[Adjuvant chemotherapy with taxoid-containing drugs in breast cancer: soon to be expected in the Netherlands].
Nederlands tijdschrift voor geneeskunde 2004;148(31):1524-8.
2004: S J T Jansen; Wilma Otten; Cornelis J H van de Velde; J W R Nortier; Anne M Stiggelbout
The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life.
British journal of cancer 2004;91(1):56-61.
2004: Willem E Fiets; J W R Nortier
A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results.
Breast cancer research : BCR 2004;6(5):185-7.
2003: Timothy J Littlewood; J W R Nortier; Bernardo Rapoport; Marek Pawlicki; Gilbert de Wasch; Els Vercammen; Wolfgang Schuette; Jacques Wils; Mathias Freund
Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Hematological oncology 2003;21(4):169-80.
2003: Paul Chr De Jong; Marinus A Blankenstein; J W R Nortier; Peter Slee; Joost van de Ven; Joost M H H van Gorp; Johannes R J Elbers; Margriet E I Schipper; Geert H Blijham; Jos H H Thijssen; Qing Lu; Danijela Jelovac; Angela Brodie
The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease.
The Journal of steroid biochemistry and molecular biology 2003;87(2-3):149-55.
2003: Willem E Fiets; R P van Helvoirt; J W R Nortier; Ingeborg van der Tweel; Henk Struikmans
Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1081-8.
2003: Geertjan van Tienhoven; M K Tuut; J W R Nortier; E J Th Rutgers
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer": an important document, but keep doors to new 'evidence' open].
Nederlands tijdschrift voor geneeskunde 2003;147(8):362, author reply 363.
2003: Jacques A Wils; Geert H Blijham; Th Wagener; J De Greve; R L H Jansen; T C Kok; J W R Nortier; Harry Bleiberg; ML Couvreur; Bruno Genicot; Benoît Baron
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.
European journal of cancer (Oxford, England : 1990) 2003;39(3):346-52.
2003: David Cella; Martin J Zagari; Christina Vandoros; Dennis D Gagnon; Hans-Jürgen Hurtz; J W R Nortier
Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):366-73.
2002: E J Th Rutgers; J W R Nortier; M K Tuut; Geertjan van Tienhoven; Henk Struikmans; Marijke Bontenbal; Maarten F von Meyenfeldt; G Vreugdenhil; T Benraadt; B Garssen; J L Peterse
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"].
Nederlands tijdschrift voor geneeskunde 2002;146(45):2144-51.
2002: Timothy J Littlewood; David Cella; J W R Nortier
Erythropoietin improves quality of life.
The lancet oncology 2002;3(8):459-60.
2002: A Pikaar; J W R Nortier; G Griffioen; H F A Vasen
[Desmoid tumors in patients with familial adenomatous polyposis].
Nederlands tijdschrift voor geneeskunde 2002;146(29):1355-9.
2002: Willem E Fiets; Marinus A Blankenstein; Henk Struikmans; H M Ruitenberg; J W R Nortier
The prognostic value of hormone receptor detection by enzyme immunoassay and immunohistochemistry: a prospective study in patients with early breast cancer.
The International journal of biological markers 2002;17(1):24-32.
2001: Angela Brodie; Qing Lu; Brian Long; Amy M Fulton; T Chen; N Macpherson; P C DeJong; Marinus A Blankenstein; J W R Nortier; Peter Slee; Joost van de Ven; Joost M H H van Gorp; Johannes R J Elbers; M E Schipper; Geert H Blijham; Jos H H Thijssen
Aromatase and COX-2 expression in human breast cancers.
The Journal of steroid biochemistry and molecular biology 2001;79(1-5):41-7.
2001: Timothy J Littlewood; E Bajetta; J W R Nortier; Els Vercammen; B Rapoport
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2865-74.
2001: Paul Chr De Jong; Marinus A Blankenstein; Joost van de Ven; J W R Nortier; Geert H Blijham; Jos H H Thijssen
Importance of local aromatase activity in hormone-dependent breast cancer: a review.
Breast (Edinburgh, Scotland) 2001;10(2):91-9.
2000: Marijke Bontenbal; J W R Nortier; Louk V A M Beex; P Bakker; Pierre Hupperets; Marianne A Nooij; H van Veelen; G Vreugdenhil; D J Richel; Geert H Blijham
[Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology].
Nederlands tijdschrift voor geneeskunde 2000;144(21):984-9.
1999: Jean-Marc Nabholtz; H J Senn; W R Bezwoda; D Melnychuk; L Deschênes; J Douma; T A Vandenberg; B Rapoport; R Rosso; Véronique Trillet-Lenoir; J Drbal; A Molino; J W R Nortier; D J Richel; T Nagykalnai; P Siedlecki; N Wilking; J Y Genot; Pierre Hupperets; F Pannuti; D Skarlos; E M Tomiak; Michael Murawsky; M Alakl; M Aapro
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1413-24.
1998: J W R Nortier; M Nooy; Louk V A M Beex
[Hormone replacement therapy after breast cancer].
Nederlands tijdschrift voor geneeskunde 1998;142(21):1229-30.
1998: Ronald de Wit; H van den Berg; J Burghouts; J W R Nortier; Peter Slee; C Rodenburg; J Keizer; M Fonteyn; Jaap Verweij; J Wils
Initial high anti-emetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles.
British journal of cancer 1998;77(9):1487-91.
1998: Peter Slee; M R Eliel; J W R Nortier; Cees J Rodenburg
[Taxoids in ovarian and breast carcinoma: the role of the medical profession and the government].
Nederlands tijdschrift voor geneeskunde 1998;142(10):502-4.